5-methoxypsoralen has been researched along with Granulocytic Leukemia, Chronic in 1 studies
5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Salvador, A | 1 |
Dall'Acqua, S | 1 |
Sardo, MS | 1 |
Caffieri, S | 1 |
Vedaldi, D | 1 |
Dall'Acqua, F | 1 |
Borgatti, M | 1 |
Zuccato, C | 1 |
Bianchi, N | 1 |
Gambari, R | 1 |
1 other study available for 5-methoxypsoralen and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen.
Topics: 5-Methoxypsoralen; Antineoplastic Agents; Cell Differentiation; Erythroid Cells; Heterocyclic Compou | 2010 |